"New medicines are being developed that are expected to transform the care of patients with hepatitis C, making treatment far more effective and far less grueling.
The new drugs, which could start reaching the market as early as next year, could help subdue a virus that infects roughly four million Americans, most of them baby boomers, and 170 million people worldwide."
Comments